Medical Technology, Funding & Government Experts Address Business, Investment, Reimbursement, Compliance, Innovation, Regulatory and Legal Issues at AdvaMed 2010

"510(K) review process, supply chain dynamics, impact of healthcare reform, comparative effectiveness, bridging the gap between body and device, mobile interfaces, medical technologies in the service of wounded warriors, data strategies, uniform device identification and much more to be covered"

WASHINGTON, Oct. 11 /PRNewswire-USNewswire/ -- More than 170 industry experts and thought leaders will participate in 35 educational panels and four executive workshops at AdvaMed 2010: The MedTech Conference, October 18-20 in Washington, D.C. Now in its fourth year, this annual medical technology industry developed and supported conference brings together stakeholders from across the U.S. and around the world.  

"This conference will attract and appeal to CEO's from across the full spectrum of the medical device industry, from the very smallest to the largest companies, as well as those involved in the business development, legal, compliance, regulatory, reimbursement, quality, government relations and communications functions," said Carroll Neubauer, Chairman and CEO of B. Braun, and Chairman of the AdvaMed 2010 Executive Conference Committee.  "Leaders from The Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), the Department of Commerce and international experts in business and regulatory matters in Canada, China, India, Japan, and the UK will all participate.  We've brought together experts to discuss the latest in personalized medicine, global harmonization, registries, health care payment and delivery reform, the 510(k) process and much more. I am extremely proud of this program and the caliber of the speakers. Without a doubt this is an outstanding and comprehensive program which will benefit all those that attend."

In addition to the panel presentations and executive workshops AdvaMed 2010 will host two "Funding Forums," six "CEO Unplugged" spotlights covering policy, distribution, business development, compliance and regulatory topics, as well as a series of sector and networking events. Keynote speakers include Dr. Donald Berwick, CMS Administrator; Dr. Margaret Hamburg, FDA Commissioner; Katie Couric, CBS News Anchor; and Gary Locke, the U. S. Secretary of Commerce.

Attendees can line up one-on-one business development meetings in advance of the conference and listen to 60 company presentations onsite. Innovations in imaging, cardiovascular, neurology, diagnostics, women's health, wound healing, blood, ophthalmology and orthopedics will be featured during the company presentation program.

"If you are part of the medical device and technology industry this is one conference you don't want to miss," added Neubauer.

About AdvaMed:

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.AdvaMed.org.

About AdvaMed 2010:

AdvaMed 2010 is the premier MedTech conference for business leaders, entrepreneurs, policymakers, media, financiers, and other industry stakeholders from around the world. In its second year, AdvaMed 2009 attracted 1,500 industry leaders – including 500+ CEOs, Presidents and C-level executives.

In today's economic and political climate, AdvaMed 2010 is this year's can't miss MedTech event for networking; conducting partnering meetings; influencing policymakers and the media; and participating in educational sessions.  Whether you need to finance, partner, or license technology; learn the latest important developments in reimbursement, regulatory, legal, intellectual property, and other critical areas; or meet with and hear from leaders in the Obama Administration and Congress, AdvaMed 2010 is your introduction to key decision-makers. For more information, visit www.AdvaMed2010.com.

SOURCE AdvaMed 2010 and AdvaMed